ARMP
Armata Pharmaceuticals Inc
NYSE MKT: ARMP · HEALTHCARE · BIOTECHNOLOGY
$9.87
+3.35% today
Updated 2026-04-30
Market cap
$366.22M
P/E ratio
—
P/S ratio
74.68x
EPS (TTM)
$-4.80
Dividend yield
—
52W range
$1 – $15
Volume
0.1M
Armata Pharmaceuticals Inc (ARMP) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
-46.1%
Last 4 quarters
Revenue YoY growth
-12.1%
Most recent quarter
EPS YoY growth
-120.6%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-3.6%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-5.5%
2025-11-12
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-19 | $-0.51 | -169.1% | $8.54 | $8.39 | -1.8% |
| 2025-11-12 | $-0.74 | -48.0% | $6.75 | $6.38 | -5.5% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.19 | $-0.51 | -169.1% | $1.08M | -12.1% |
| 2025-09-30 | $-0.50 | $-0.74 | -48.0% | $1.16M | -61.0% |
| 2025-06-30 | $-0.39 | $-0.45 | -15.4% | $2.17M | — |
| 2025-03-31 | $-0.38 | $-0.20 | +48.1% | $491000.00 | -49.2% |
| 2024-12-31 | $-0.35 | $-0.23 | +33.8% | $1.24M | -19.2% |
| 2024-09-30 | $-0.28 | $-0.15 | +46.4% | $2.97M | +142.7% |
| 2024-06-30 | $-0.44 | $0.25 | +156.8% | — | — |
| 2024-03-31 | $-0.31 | $-0.69 | -122.6% | $966000.00 | +21.4% |
| 2023-12-31 | $-0.35 | $-0.55 | -57.1% | $1.53M | — |
| 2023-09-30 | $-0.31 | $-0.75 | -141.9% | $1.23M | — |
| 2023-06-30 | $-0.37 | $-0.10 | +73.0% | $980000.00 | — |
| 2023-03-31 | $-0.32 | $-0.40 | -25.0% | $796000.00 | — |
Frequently asked questions
Has Armata Pharmaceuticals Inc beaten earnings estimates?
Armata Pharmaceuticals Inc has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of -46.1% over the last 4 quarters.
How does ARMP stock react to earnings?
ARMP stock has moved an average of -3.6% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.
What is Armata Pharmaceuticals Inc's revenue growth rate?
Armata Pharmaceuticals Inc reported year-over-year revenue growth of -12.1% in its most recent quarter, with EPS growing -120.6% year-over-year.